{"id":552,"date":"2020-01-24T12:42:10","date_gmt":"2020-01-24T07:12:10","guid":{"rendered":"http:\/\/www.cscr.in\/symposium\/?page_id=552"},"modified":"2020-01-24T12:42:57","modified_gmt":"2020-01-24T07:12:57","slug":"cgts-2019","status":"publish","type":"page","link":"https:\/\/www.cscr.res.in\/symposium\/index.php\/cgts-2019\/","title":{"rendered":"CGTS 2019"},"content":{"rendered":"

PROGRAMME SCHEDULE<\/u><\/strong><\/p>\n

DAY-1: THURSDAY, 05TH<\/sup> SEPTEMBER, 2019<\/strong><\/p>\n

8:00 to 8:45AM: REGISTRATION<\/strong><\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
8:45 to 8:50AM<\/p>\n

\u00a0<\/strong><\/p>\n

8:50 to 9:00AM<\/p>\n

 <\/p>\n

9:00 to 9:05AM<\/p>\n

 <\/p>\n

9:05 to 9:10AM<\/p>\n

\u00a0<\/strong><\/p>\n

\u00a0<\/strong><\/p>\n

9:10 to 9:15AM<\/td>\n

Prayer<\/p>\n

 <\/p>\n

Welcome and introductory remarks \u2013 Dr. J. V. Peter,<\/strong> Director \/ Dr. Anna Pulimood, Principal, CMC<\/strong><\/p>\n

 <\/p>\n

Address by Dr. Renu Swarup<\/strong>, Secretary, Department of Biotechnology (DBT), Govt. of India<\/p>\n

 <\/p>\n

Address by Dr. Balram Bhargava<\/strong>, Secretary, Department of Health Research (DHR), Govt. of India & Director General, Indian Council of Medical Research (ICMR)<\/p>\n

 <\/p>\n

Address by Dr. V. G. Somani<\/strong>, Drug Controller General (India), Central Drugs Standard Control Organisation (CDSCO), Govt. of India<\/td>\n<\/tr>\n

Session-1: <\/em><\/strong>\u00a0IMMUNE CELL THERAPY<\/strong><\/td>\n<\/tr>\n
Chair: <\/em><\/strong>Shubhada Chiplunkar<\/strong><\/td>\n<\/tr>\n
9:20 to 9:25AM<\/td>\nIntroduction to the session<\/td>\n<\/tr>\n
9:25 to 9:55AM<\/td>\nDeveloping ligand-based chimeric antigen receptors to target leukemic and bone marrow stem cells<\/td>\nTrent Spencer<\/strong><\/p>\n

Emory University<\/p>\n

School of Medicine, USA<\/td>\n<\/tr>\n

9:55 to 10:25AM<\/td>\nTranslating indigenous CAR T cell therapy from lab to clinic<\/td>\nRahul Purwar<\/strong><\/p>\n

Indian Institute of Technology Bombay, India<\/td>\n<\/tr>\n

10:25 to 10:55AM<\/td>\nThird party antigen specific T cells for treatment of virus infections after allogeneic stem cell transplant<\/td>\nDavid Gottlieb<\/strong><\/p>\n

Westmead Hospital Sydney, Australia<\/td>\n<\/tr>\n

10:55 to 11:25AM<\/td>\nTea \/ Coffee Break<\/em><\/strong><\/td>\n<\/tr>\n
Session-2: <\/em><\/strong>\u00a0APPLICATIONS OF iPSC TECHNOLOGY<\/strong><\/td>\n<\/tr>\n
Chair: <\/em><\/strong>Raghu Padinjat<\/strong><\/td>\n<\/tr>\n
11:25 to 11:30AM<\/td>\nIntroduction to the session<\/td>\n<\/tr>\n
11:30 to 12:00PM<\/td>\nInternational quality standards for clinical-grade induced pluripotent stem cells<\/td>\nStephen Sullivan<\/strong><\/p>\n

Global Alliance for iPSC Therapies, UK<\/td>\n<\/tr>\n

12:00 to 12:30PM<\/td>\nClinically compliant culture systems for the iPSC work flow<\/td>\nRoland Leathers<\/strong><\/p>\n

Thermo Fisher Scientific,<\/p>\n

Switzerland<\/td>\n<\/tr>\n

12:30 to 1:00PM<\/td>\nApplication of iPSCs for understanding the molecular basis of neurological diseases<\/td>\nOdity Mukherjee<\/strong><\/p>\n

Institute for Stem Cell Science and Regenerative Medicine, India<\/td>\n<\/tr>\n

1:00 to 2:00PM<\/td>\nLunch<\/em><\/strong><\/td>\n<\/tr>\n
Session-3:<\/em><\/strong> TECHNOLOGY ADVANCES<\/strong><\/td>\n<\/tr>\n
Chair: <\/em><\/strong>Rita Mulherkar<\/strong><\/td>\n<\/tr>\n
2:00 to 2:05PM<\/td>\nIntroduction to the session<\/td>\n<\/tr>\n
2:05 to 2:35PM<\/td>\nDevelopment of AAV vectors capable of evading neutralizing antibodies and dampening the host humoral immune response<\/p>\n

 <\/td>\n

Arun Srivastava<\/strong><\/p>\n

University of Florida<\/p>\n

College of Medicine, USA<\/td>\n<\/tr>\n

2:35 to 3:05PM<\/td>\nCRISPR 2.0: Tackling the specificity problem<\/td>\nDebojyoti Chakraborty<\/strong><\/p>\n

CSIR-Institute of Genomics and Integrative Biology, India<\/td>\n<\/tr>\n

3:05 to 3:35PM<\/td>\nVector manufacturing for bench vs bedside: Bridging the chasm between preclinical and clinical manufacturing strategies<\/td>\nTrent Spencer<\/strong><\/p>\n

Emory University<\/p>\n

School of Medicine, USA<\/td>\n<\/tr>\n

3:35 to 4:35PM<\/td>\nTea \/ Coffee Break with Poster Session<\/em><\/strong><\/td>\n<\/tr>\n
 <\/p>\n

 <\/p>\n

Session-4:<\/em><\/strong> MANUFACTURING AND REGULATORY ASPECTS IN CELL AND GENE THERAPY<\/strong><\/td>\n<\/tr>\n

Chair: <\/em><\/strong>Thangarajan Rajkumar<\/strong><\/td>\n<\/tr>\n
4:35 to 4:40PM<\/td>\nIntroduction to the session<\/td>\n<\/tr>\n
4:40 to 5:10PM<\/td>\nGood manufacturing practice for pluripotent stem cell for clinical grade application<\/td>\nMahendra Rao<\/strong><\/p>\n

Institute for Stem Cell Science and Regenerative Medicine, India<\/td>\n<\/tr>\n

5:10 to 5:40PM<\/td>\nQuality control for hPSC lines and hPSC-based products<\/td>\nGlyn Stacey<\/strong><\/p>\n

International Stem Cell Banking<\/p>\n

Initiative, UK<\/td>\n<\/tr>\n

5:40 to 6:10PM<\/td>\nManufacturing of advanced therapy medicinal products in a European academic setting<\/td>\nPontus Blomberg<\/strong><\/p>\n

Karolinska Institutet and Karolinska University Hospital, Sweden<\/td>\n<\/tr>\n

KEY NOTE ADDRESS<\/strong><\/td>\n<\/td>\n<\/tr>\n
Chair: <\/em><\/strong>Alok Srivastava<\/strong><\/td>\n<\/td>\n<\/tr>\n
6:10 to 6:15PM<\/td>\nIntroduction<\/td>\n<\/td>\n<\/tr>\n
6:15 to 7:15PM<\/td>\nEvolution of T- cell therapy for infections<\/td>\nDavid Gottlieb<\/strong><\/p>\n

Westmead Hospital Sydney, Australia<\/td>\n

<\/td>\n<\/tr>\n
7:15PM onwards<\/td>\nDinner<\/em><\/strong><\/td>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

DAY-2: FRIDAY, 06TH<\/sup> SEPTEMBER, 2019<\/strong><\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Session-5:<\/em><\/strong> GENE EDITING<\/strong><\/td>\n<\/tr>\n
Chair: <\/em><\/strong>R V Shaji<\/strong><\/td>\n<\/tr>\n
8:00 to 8:05AM<\/td>\nIntroduction to the session<\/td>\n<\/tr>\n
8:05 to 8:35AM<\/td>\nHigh-level Cas9-mediated correction of the sickle mutation in human hematopoietic stem cells<\/td>\nDavid Martin<\/strong><\/p>\n

Children’s Hospital Oakland Research Institute, USA<\/td>\n<\/tr>\n

8:35 to 9:05AM<\/td>\nRewinding the internal clock of hemoglobin synthesis in adult stem cells<\/td>\nSivaprakash Ramalingam<\/strong><\/p>\n

CSIR-Institute of Genomics and Integrative Biology, India<\/td>\n<\/tr>\n

9:05 to 9:35AM<\/td>\nTherapeutic Gene editing at the \u03b2-globin locus<\/td>\nSowmya Pattabhi<\/strong><\/p>\n

Seattle Children’s Research Institute, USA<\/td>\n<\/tr>\n

9:35 to 10:05AM<\/td>\nCrispr-Cas9 mediated HPFH like mutations for fetal hemoglobin reactivation<\/td>\nSaravanabhavan Thangavel<\/strong><\/p>\n

Centre for Stem Cell Research, India<\/td>\n<\/tr>\n

10:05 to 11:05AM<\/td>\nTea \/ Coffee Break with Poster Session<\/em><\/strong><\/td>\n<\/tr>\n
 <\/p>\n

 <\/p>\n

Session-6:<\/em><\/strong> GENE THERAPY<\/strong><\/td>\n<\/tr>\n

Chair: <\/em><\/strong>Alok Srivastava<\/strong><\/td>\n<\/tr>\n
11:05 to 11:10AM<\/td>\nIntroduction to the session<\/td>\n<\/tr>\n
11:10 to 11:40AM<\/td>\nEmerging roles of transgene mutations in gene therapy products for hemophilia<\/td>\nChristopher Doering<\/strong><\/p>\n

Emory University<\/p>\n

School of Medicine, USA<\/td>\n<\/tr>\n

11:40 to 12:10PM<\/td>\nThe role of miRNA17-92 cluster in AAV vector-mediated transgene expression<\/td>\nArun Srivastava<\/strong><\/p>\n

University of Florida<\/p>\n

College of Medicine, USA<\/td>\n<\/tr>\n

12:10 to 12:40PM<\/td>\nNext-generation gene therapy and gene editing for muscle disorders<\/td>\nThierry VandenDriessche<\/strong><\/p>\n

Free University of Brussels & University of Leuven, Belgium<\/td>\n<\/tr>\n

12:40 to 1:10PM<\/td>\nTargeting erythroid specific BCL11A enhancer in hematopoietic stem and progenitor cells for the therapeutic induction of fetal hemoglobin<\/td>\nMohankumar Murugesan<\/strong><\/p>\n

Centre for Stem Cell Research, India<\/td>\n<\/tr>\n

1:10 to 2:10PM<\/td>\nLunch<\/em><\/strong><\/td>\n<\/tr>\n
 <\/p>\n

 <\/p>\n

Session-7:<\/em><\/strong> CELL THERAPY IN OCULAR DISORDERS<\/strong><\/td>\n<\/tr>\n

Chair: <\/em><\/strong>Arkasubhra Ghosh<\/strong><\/td>\n<\/tr>\n
2:10 to 2:15PM<\/td>\nIntroduction to the session<\/td>\n<\/tr>\n
2:15 to 2:45PM<\/td>\nLimbal derived stem cells in corneal and limbal wound healing<\/td>\nVivek Singh <\/strong><\/p>\n

L.V. Prasad Eye Institute,<\/p>\n

India<\/td>\n<\/tr>\n

2:45 to 3:15PM<\/td>\nCell Therapy of corneal diseases with umbilical mesenchymal stem \/ stromal cells<\/td>\nWinston W-Y Kao<\/strong><\/p>\n

University of Cincinnati, USA<\/td>\n<\/tr>\n

3:15 to 3:45PM<\/td>\nRetinal cell replacement in macular degeneration: A pluripotent stem cell-based approach<\/td>\nRajarshi Pal<\/strong><\/p>\n

Eyestem Research Private Limited, India<\/td>\n<\/tr>\n

3:45 to 4:00PM<\/td>\nConclusion remarks<\/em><\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

<\/h3>\n

CGTS 2019 ABSTRACT BOOK – Click to view \/ download<\/a><\/h3>\n

CGTS 2019 SCIENTIFIC PROGRAM – Click to view \/ download<\/a><\/h3 \n\n","protected":false},"excerpt":{"rendered":"

PROGRAMME SCHEDULE DAY-1: THURSDAY, 05TH SEPTEMBER, 2019 8:00 to 8:45AM: REGISTRATION 8:45 to 8:50AM \u00a0 8:50 to 9:00AM   9:00 to 9:05AM   9:05 to 9:10AM \u00a0 \u00a0 9:10 to 9:15AM Prayer   Welcome and introductory remarks \u2013 Dr. J. V. Peter, Director \/ Dr. Anna Pulimood, Principal, CMC   Address by Dr. Renu Swarup, […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/www.cscr.res.in\/symposium\/index.php\/wp-json\/wp\/v2\/pages\/552"}],"collection":[{"href":"https:\/\/www.cscr.res.in\/symposium\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.cscr.res.in\/symposium\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.cscr.res.in\/symposium\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cscr.res.in\/symposium\/index.php\/wp-json\/wp\/v2\/comments?post=552"}],"version-history":[{"count":2,"href":"https:\/\/www.cscr.res.in\/symposium\/index.php\/wp-json\/wp\/v2\/pages\/552\/revisions"}],"predecessor-version":[{"id":555,"href":"https:\/\/www.cscr.res.in\/symposium\/index.php\/wp-json\/wp\/v2\/pages\/552\/revisions\/555"}],"wp:attachment":[{"href":"https:\/\/www.cscr.res.in\/symposium\/index.php\/wp-json\/wp\/v2\/media?parent=552"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}